A common SCN5A variant alters the responsiveness of human sodium channels to class I antiarrhythmic agents.

Background: The potential pathophysiological role of common SCN5A polymorphisms in cardiac arrhythmias has been increasingly recognized. However, little is known about the impact of those polymorphisms on the pharmocological response of hNav1.5 to various antiarrhythmic agents.